Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified. more
| Time Frame | PBE | S&P500 |
|---|---|---|
| 1-Week Return | -0.79% | 0.01% |
| 1-Month Return | 9.43% | 3.54% |
| 3-Month Return | 15.72% | 10.58% |
| 6-Month Return | 10.23% | 8.03% |
| 1-Year Return | 35.55% | 20.06% |
| 3-Year Return | 49.75% | 70.98% |
| 5-Year Return | 19.72% | 71.89% |
| 10-Year Return | 132.91% | 252.66% |
| Time Frame | PBE | S&P500 |
|---|---|---|
| 1-Week Return | -33.87% | 0.52% |
| 1-Month Return | 199.34% | 52.69% |
| 3-Month Return | 80.78% | 50.36% |
| 6-Month Return | 21.84% | 16.96% |
| 1-Year Return | 35.55% | 20.06% |
| 3-Year Return | 14.41% | 19.58% |
| 5-Year Return | 3.67% | 11.44% |
| 10-Year Return | 8.82% | 13.43% |
| Stock name | Ticker | Weight |
|---|---|---|
Vertex Pharmaceuticals Inc
|
VRTX |
4.99%
|
Amgen Inc
|
AMGN |
4.74%
|
Royalty Pharma PLC
|
RPRX |
4.71%
|
Alnylam Pharmaceuticals Inc
|
ALNY |
4.63%
|
Regeneron Pharmaceuticals Inc
|
REGN |
4.61%
|
Biogen Inc
|
BIIB |
4.51%
|
Gilead Sciences Inc
|
GILD |
4.41%
|
United Therapeutics Corp
|
UTHR |
4.18%
|
Bio-Techne Corp
|
TECH |
3.54%
|
Vericel Corp
|
VCEL |
3.3%
|
Protagonist Therapeutics Inc
|
PTGX |
3.29%
|
CareDx Inc
|
CDNA |
3.23%
|
Veracyte Inc
|
VCYT |
3.2%
|
Illumina Inc
|
ILMN |
3.19%
|
PTC Therapeutics Inc
|
PTCT |
3.16%
|
BioCryst Pharmaceuticals Inc
|
BCRX |
3.02%
|
Repligen Corp
|
RGEN |
2.98%
|
ACADIA Pharmaceuticals Inc
|
ACAD |
2.97%
|
Sarepta Therapeutics Inc
|
SRPT |
2.94%
|
Incyte Corp
|
INCY |
2.91%
|
QIAGEN NV
|
QIAGEN.NV |
2.82%
|
Neurocrine Biosciences Inc
|
NBIX |
2.77%
|
AnaptysBio Inc
|
ANAB |
2.75%
|
Halozyme Therapeutics Inc
|
HALO |
2.73%
|
Exelixis Inc
|
EXEL |
2.73%
|
BioMarin Pharmaceutical Inc
|
BMRN |
2.71%
|
Collegium Pharmaceutical Inc
|
COLL |
2.53%
|
Legend Biotech Corp
|
LEGN |
2.21%
|
Omeros Corp
|
OMER |
2.1%
|
Ardelyx Inc
|
ARDX |
2.06%
|
Invesco Government & Agency Portfolio
|
Invesco.Government...Agency.Portfolio |
0.09%
|
CASH & EQUIVALENTS
|
CASH...EQUIVALENTS |
0%
|
SECURITIES LENDING - BNYM
|
SECURITIES.LENDING...BNYM |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
Invesco Dynamic Biotechnology & Genome ETF (PBE) share price today is $91.1733.
Yes, Indians can buy shares of Invesco Dynamic Biotechnology & Genome ETF (PBE) on Vested. To buy PBE from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Invesco Dynamic Biotechnology & Genome ETF (PBE) on Vested. You can start investing in Invesco Dynamic Biotechnology & Genome ETF (PBE) with a minimum investment of $1.
The 52-week high price of Invesco Dynamic Biotechnology & Genome ETF (PBE) is $94.06. The 52-week low price of Invesco Dynamic Biotechnology & Genome ETF (PBE) is $62.71.
The stock symbol (or ticker) of Invesco Dynamic Biotechnology & Genome ETF is PBE.
Yes, you can setup SIP in Invesco Dynamic Biotechnology & Genome ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of PBE on the Vested app.
The expense ratio of Invesco Dynamic Biotechnology & Genome ETF (PBE) is 0.58%.
Link copied